We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mitochondrial Genome of Previously Unknown Human Species Decoded

By LabMedica International staff writers
Posted on 29 Apr 2010
An international team of researchers has sequenced ancient mitochondrial DNA from a finger bone of a female found in southern Siberia. More...
She comes from a previously unknown human species, which lived approximately 48,000 to 30,000 years ago in the Altai Mountains in Central Asia.

The mitochondrial genome that was inherited from the mother and passed on to the descendants is an indication of a new wave of emigration from Africa. It differs from the Homo erectus ancestors of Neanderthals and Homo sapiens, according to a study published in the March 25, 2010, issue of the journal Nature.

The first group of hominins, which left Africa about 1.9 million years ago, was Homo erectus. Archaeological findings and genetic data suggest that at least two other groups then left Africa: First, about 500,000 to 300,000 years ago, the ancestors of Neanderthals, and after that, 50,000 years ago, anatomically modern humans. Direct descendants of Homo erectus could have survived until less than 100,000 years ago in Indonesia. Earlier representatives of Homo erectus and Homo heidelbergensis lived in northern latitudes--for example, more than 125,000 years in the Altai Mountains in southern Siberia. Neanderthals also lived at that time in Siberia.

Dr. Johannes Krause, Dr. Svante Pääbo and colleagues from the Max Planck Institute for Evolutionary Anthropology (Leipzig, Germany) have now sequenced mitochondrial DNA from a tiny piece of a finger bone. The bone was found 2008 in the Denisova Cave in the Altai Mountains in southern Siberia. They compared the ancient DNA from the mitochondria, with the mitochondrial DNA of Neanderthals and living humans. It was revealed that the mitochondrial DNA of the hominins from South Siberia differs noticeably from that of all previously known hominins.

As demonstrated by a detailed examination of the mitochondrial genome, these hominins shared a common ancestor with modern humans and Neanderthals approximately 1.0 million years ago. Moreover, the age of the fossil suggests that these unknown people in Southern Siberia lived close in time and space with Neanderthals as well as with modern humans.

Related Links:
Max Planck Institute for Evolutionary Anthropology



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.